These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

256 related articles for article (PubMed ID: 19057395)

  • 21. Epidemiological study of ulcerative colitis in Japan: incidence and familial occurrence. The Epidemiology Group of the Research Committee of Inflammatory Bowel Disease in Japan.
    Kitahora T; Utsunomiya T; Yokota A
    J Gastroenterol; 1995 Nov; 30 Suppl 8():5-8. PubMed ID: 8563890
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Intestinal protozoa infections among patients with ulcerative colitis: prevalence and impact on clinical disease course.
    Yamamoto-Furusho JK; Torijano-Carrera E
    Digestion; 2010; 82(1):18-23. PubMed ID: 20145404
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The prevalence of ulcerative colitis in Israel: a twenty-year survey.
    Birkenfeld S; Zvidi I; Hazazi R; Niv Y
    J Clin Gastroenterol; 2009 Sep; 43(8):743-6. PubMed ID: 19369888
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Colorectal carcinoma in ulcerative colitis is decreasing in Scandinavian countries.
    Rubio CA; Befrits R; Ljung T; Jaramillo E; Slezak P
    Anticancer Res; 2001; 21(4B):2921-4. PubMed ID: 11712787
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Predictors of persistence with 5-aminosalicylic acid therapy for ulcerative colitis.
    Kane SV; Accortt NA; Magowan S; Brixner D
    Aliment Pharmacol Ther; 2009 Apr; 29(8):855-62. PubMed ID: 19183154
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Aminosalicylate therapy in the prevention of dysplasia and colorectal cancer in ulcerative colitis.
    Rubin DT; LoSavio A; Yadron N; Huo D; Hanauer SB
    Clin Gastroenterol Hepatol; 2006 Nov; 4(11):1346-50. PubMed ID: 17059900
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ulcerative colitis and pregnancy].
    Ida A; Koyama K
    Nihon Rinsho; 1999 Nov; 57(11):2603-7. PubMed ID: 10572439
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impact of cessation of smoking on the course of ulcerative colitis.
    Beaugerie L; Massot N; Carbonnel F; Cattan S; Gendre JP; Cosnes J
    Am J Gastroenterol; 2001 Jul; 96(7):2113-6. PubMed ID: 11467641
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Difficulties in taking aminosalicylates for patients with ulcerative colitis.
    Kawakami A; Tanaka M; Ochiai R; Naganuma M; Iwao Y; Hibi T; Kazuma K
    Gastroenterol Nurs; 2012; 35(1):24-31. PubMed ID: 22306727
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).
    Solberg IC; Lygren I; Jahnsen J; Aadland E; Høie O; Cvancarova M; Bernklev T; Henriksen M; Sauar J; Vatn MH; Moum B;
    Scand J Gastroenterol; 2009; 44(4):431-40. PubMed ID: 19101844
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Natural history of paediatric inflammatory bowel diseases over a 5-year follow-up: a retrospective review of data from the register of paediatric inflammatory bowel diseases.
    Newby EA; Croft NM; Green M; Hassan K; Heuschkel RB; Jenkins H; Casson DH
    J Pediatr Gastroenterol Nutr; 2008 May; 46(5):539-45. PubMed ID: 18493209
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Course and natural history of idiopathic ulcerative proctitis in adults].
    Ghirardi M; Nascimbeni R; Mariani PP; Di Fabio F; Salerni B
    Ann Ital Chir; 2002; 73(2):155-8; discussion 158-9. PubMed ID: 12197289
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Duration of remission and long-term prognosis according to the extent of disease in patients with ulcerative colitis on continuous mesalamine treatment.
    Bresci G; Parisi G; Capria A
    Colorectal Dis; 2008 Oct; 10(8):814-7. PubMed ID: 18834420
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Review article: new drug formulations, chemical entities and therapeutic approaches for the management of ulcerative colitis.
    Ng SC; Kamm MA
    Aliment Pharmacol Ther; 2008 Oct; 28(7):815-29. PubMed ID: 18627362
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Incidence and natural history of ulcerative colitis in the Uppsala Region of Sweden 2005-2009 - results from the IBD cohort of the Uppsala Region (ICURE).
    Sjöberg D; Holmström T; Larsson M; Nielsen AL; Holmquist L; Ekbom A; Rönnblom A
    J Crohns Colitis; 2013 Oct; 7(9):e351-7. PubMed ID: 23491313
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ulcerative colitis: pathogenesis, diagnosis, and current treatment.
    Griffel LH; Das KM
    J Assoc Acad Minor Phys; 1996; 7(3):63-9. PubMed ID: 8803417
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Clinical and epidemiological profile of ulcerative colitis in a hospital in Lima].
    Calderón AV; Velarde OF; Yoshidaira MY; Barahona ER
    Rev Gastroenterol Peru; 2004; 24(2):135-42. PubMed ID: 15241492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ulcerative colitis: analyses of 116 cases (do extraintestinal manifestations effect the time to catch remission?).
    Ozdil S; Akyüz F; Pinarbasi B; Demir K; Karaca C; Boztas G; Kaymakoglu S; Mungan Z; Besisik F; Cakaloglu Y; Okten A
    Hepatogastroenterology; 2004; 51(57):768-70. PubMed ID: 15143912
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and tolerability of olsalazine (dipentum) in the treatment of patients with ulcerative colitis--results of a field study.
    Singer MV; Schmausser H; Schönfeld G
    Hepatogastroenterology; 2006; 53(69):317-21. PubMed ID: 16795963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Incidence and prevalence of inflammatory bowel disease in a Northern California managed care organization, 1996-2002.
    Herrinton LJ; Liu L; Lewis JD; Griffin PM; Allison J
    Am J Gastroenterol; 2008 Aug; 103(8):1998-2006. PubMed ID: 18796097
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.